Back
Cellectar Biosciences Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
23
CLRB
Cellectar Biosciences
Last Price:
0.26
Seasonality Move:
-1.67%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Sell |
| 20-day SMA: | 1.43 | Sell |
| 50-day SMA: | 1.82 | Sell |
| 200-day SMA: | 2.6 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.34 | Sell |
| 50-day EMA: | 1.69 | Sell |
| 200-day EMA: | 2.29 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 5.91 | Sell |
| Chaikin Money Flow: | -6267615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.11 - 2.03) | Sell |
| Bollinger Bands (100): | (1.63 - 2.29) | Sell |
Cellectar Biosciences Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 0.26 while CLRB 8-day simple moving average is 1.11, which is a Sell signal.
- The stock price of CLRB is 0.26 while Cellectar Biosciences 20-day SMA is 1.43, which makes it a Sell.
- Cellectar Biosciences 50-day simple moving average is 1.82 while CLRB share price is 0.26, making it a Sell technically.
- CLRB stock price is 0.26 and Cellectar Biosciences 200-day simple moving average is 2.60, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
23
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a Sell
The current Cellectar Biosciences [CLRB] share price is $0.26. The Score for CLRB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
10.9M
Price in USD:
0.26
Share Volume:
11.49M
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
0.25
Sell
23
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?
The Cellectar Biosciences stock price is 0.26 USD today. -
Will CLRB stock go up or go down?
Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Cellectar Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 0.26 while CLRB 8-day exponential moving average is 0.97, which is a Sell signal.
- The stock price of CLRB is 0.26 while Cellectar Biosciences 20-day EMA is 1.34, which makes it a Sell.
- Cellectar Biosciences 50-day exponential moving average is 1.69 while CLRB share price is 0.26, making it a Sell technically.
- CLRB stock price is 0.26 and Cellectar Biosciences 200-day simple moving average is 2.29, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.81 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
- CLRB Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Cellectar Biosciences is a Sell
- Cellectar Biosciences Relative Strength Index (RSI) is 5.91, which suggest Cellectar Biosciences is oversold
- The Bollinger Bands (25) for Cellectar Biosciences is (1.11 - 2.03), which suggest Cellectar Biosciences is a Sell
- The Bollinger Bands (100) for Cellectar Biosciences is (1.63 - 2.29), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.